| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_656c35ff3bab0778e52171ab52185879 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10034 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| filingDate |
2007-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b3dc9510bd59daa0f514c6be05d61c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ee9a358db7671eeee47269756cdf8be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b73cd30ff17db511473da868f64cd9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb95ba9145ac1f0e0b8dc54a09fcfad8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8989db36e3c651ba46bb1044b2f1955d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_602b151199fc39117ff2289cc1de22b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_177cd8c8252f71ecfab0a4257e6cd1d7 |
| publicationDate |
2019-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3466442-A1 |
| titleOfInvention |
Treatment of mda seropositive pigs with pcv2 antigen |
| abstract |
The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age. comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets. |
| priorityDate |
2006-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |